MIT and the MIT-IBM Watson AI Lab have developed a machine-learning accelerator chip that enhances data security for health-monitoring and AI-powered apps. The chip is designed to withstand the most common types of attacks, protect sensitive information, and allow for efficient operation. Despite making devices slightly more expensive and less energy-efficient, the researchers believe the security advantage outweighs these factors in certain circumstances.
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
